Stock-Based Compensation

9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and nine months ended September 30, 2014 and 2013, was as follows:



	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014			2013		2014		2013
Cost of goods sold	$	240		$	123	$	643	$	500
Operating expenses:
Research and development	207			116		543		512
Clinical and regulatory affairs	(195		)	390		67		828
Marketing and sales	931			736		2,125		2,401
General and administrative	632			354		2,190		1,805
Total operating expenses	$	1,575		$	1,596	$	4,925	$	5,546
Total	$	1,815		$	1,719	$	5,568	$	6,046

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References+ Details